1. Home
  2. ARTL vs AKAN Comparison

ARTL vs AKAN Comparison

Compare ARTL & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • AKAN
  • Stock Information
  • Founded
  • ARTL 2011
  • AKAN 2021
  • Country
  • ARTL United States
  • AKAN Canada
  • Employees
  • ARTL N/A
  • AKAN N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • AKAN Medicinal Chemicals and Botanical Products
  • Sector
  • ARTL Health Care
  • AKAN Health Care
  • Exchange
  • ARTL Nasdaq
  • AKAN Nasdaq
  • Market Cap
  • ARTL 3.1M
  • AKAN 3.2M
  • IPO Year
  • ARTL N/A
  • AKAN 2022
  • Fundamental
  • Price
  • ARTL $9.76
  • AKAN $1.31
  • Analyst Decision
  • ARTL Buy
  • AKAN
  • Analyst Count
  • ARTL 2
  • AKAN 0
  • Target Price
  • ARTL $30.00
  • AKAN N/A
  • AVG Volume (30 Days)
  • ARTL 1.4M
  • AKAN 64.5K
  • Earning Date
  • ARTL 08-12-2025
  • AKAN 07-15-2025
  • Dividend Yield
  • ARTL N/A
  • AKAN N/A
  • EPS Growth
  • ARTL N/A
  • AKAN N/A
  • EPS
  • ARTL N/A
  • AKAN N/A
  • Revenue
  • ARTL N/A
  • AKAN $836,664.00
  • Revenue This Year
  • ARTL N/A
  • AKAN N/A
  • Revenue Next Year
  • ARTL N/A
  • AKAN N/A
  • P/E Ratio
  • ARTL N/A
  • AKAN N/A
  • Revenue Growth
  • ARTL N/A
  • AKAN 97.47
  • 52 Week Low
  • ARTL $4.92
  • AKAN $0.93
  • 52 Week High
  • ARTL $25.58
  • AKAN $5.08
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 60.38
  • AKAN 53.56
  • Support Level
  • ARTL $9.11
  • AKAN $1.28
  • Resistance Level
  • ARTL $13.22
  • AKAN $1.49
  • Average True Range (ATR)
  • ARTL 1.83
  • AKAN 0.09
  • MACD
  • ARTL 0.47
  • AKAN -0.00
  • Stochastic Oscillator
  • ARTL 21.64
  • AKAN 57.89

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About AKAN Akanda Corp.

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.

Share on Social Networks: